Share on StockTwits

Celsion (NASDAQ:CLSN) CEO Michael H. Tardugno acquired 4,000 shares of Celsion stock on the open market in a transaction dated Friday, August 15th. The stock was purchased at an average price of $3.12 per share, with a total value of $12,480.00. Following the transaction, the chief executive officer now directly owns 74,521 shares in the company, valued at approximately $232,506. The transaction was disclosed in a filing with the SEC, which is available at this link.

Separately, analysts at Paradigm Capital raised their price target on shares of Celsion from $12.50 to $13.50 in a research note on Thursday, July 17th. They now have a “buy” rating on the stock.

Shares of Celsion (NASDAQ:CLSN) traded down 3.44% during mid-day trading on Friday, hitting $3.09. 232,132 shares of the company’s stock traded hands. Celsion has a 52-week low of $2.82 and a 52-week high of $6.6216. The stock’s 50-day moving average is $3.24 and its 200-day moving average is $3.39. The company’s market cap is $53.2 million.

Celsion (NASDAQ:CLSN) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.38) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.32) by $0.06. Analysts expect that Celsion will post $-1.33 EPS for the current fiscal year.

Celsion Corporation (NASDAQ:CLSN) is an oncology drug development company focused on improving treatment for those suffering with aggressive and difficult to treat forms of cancer.

Receive News & Ratings for Celsion Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsion Co and related companies with Analyst Ratings Network's FREE daily email newsletter.